Please login to the form below

Not currently logged in
Email:
Password:

New member for Millennium Pharmaceuticals board

Millennium Pharmaceuticals has elected Dr Jeffrey M Leiden to its board of directors.

Millennium Pharmaceuticals has elected Dr Jeffrey M Leiden to its board of directors.

Dr Leiden, currently managing director at life sciences venture capital firm, Clarus Ventures, has over 20 years of experience in the biomedical and pharmaceutical sectors.

Prior to joining Clarus, Leiden served as President and COO of the global Pharmaceutical business of US pharmaceutical company, Abbott Laboratories.

Before joining Abbott in 2000, Leiden was the Elkan R Blout professor of biological sciences at Harvard School of Public Health, as well as professor of medicine at Harvard Medical School. Before his career at Harvard, he served as professor of medicine and pathology and chief of cardiology at the University of Chicago, School of Medicine. Leiden has also co-founded several biotechnology firms.

"It is a pleasure to have Dr Leiden join the Millennium Board of Directors," said Deborah Dunsire, Millennium's CEO, "We believe his diverse pharmaceutical and scientific experience will enable him to help guide our continued growth and success in our mission of delivering vital medicines to patients."

Leiden joins as an independent director and brings the number of Millennium board members to ten.

30th September 2008

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Streaming Well

Streaming Well is a healthcare focused, award-winning video production company which operates in the US and Europe....

Latest intelligence

Is the pharma business model ready for precision medicine?
Precision medicine promises to revolutionise patient outcomes and reduce costs for industry but is pharma ready for it? Blue Latitude Health co-founder Head of Strategy Fred Bassett explores the challenges...
ABPI2018
The NHS and ABPI at 70: inching closer to the triple win
The NHS and UK pharma’s ABPI both turn 70 this year. After years of transactional relationships, there’s a will to work more closely - but friction on prices and value...
What pharma marketers can learn from behavioural science
Pharma behavioural science and traditional emotional marketing create a powerful mix of techniques that have impact on real lives....

Infographics